Home/Filings/4/0001061983-15-000011
4//SEC Filing

CYTOKINETICS INC 4

Accession 0001061983-15-000011

$CYTKCIK 0001061983operating

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 2:43 PM ET

Size

15.1 KB

Accession

0001061983-15-000011

Insider Transaction Report

Form 4
Period: 2015-03-11
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
  • Sale

    Common Stock

    2015-03-11$7.80/sh19,390$151,24223,646 total
  • Sale

    Common Stock

    2015-03-11$7.80/sh1,345$10,49121,261 total
  • Exercise/Conversion

    Common Stock

    2015-03-11$6.30/sh+2,485$15,65623,746 total
  • Sale

    Common Stock

    2015-03-11$7.83/sh100$78323,646 total
  • Exercise/Conversion

    Common Stock

    2015-03-11$6.30/sh+19,390$122,15743,036 total
  • Sale

    Common Stock

    2015-03-11$7.81/sh1,040$8,12222,606 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-03-112,4857,292 total
    Exercise: $6.30From: 2012-04-05Exp: 2022-03-05Common Stock (2,485 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2015-03-1119,3900 total
    Exercise: $6.30From: 2012-04-05Exp: 2022-03-05Common Stock (19,390 underlying)

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeoperating

Related Parties

1
  • filerCIK 0001061983

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 2:43 PM ET
Size
15.1 KB